Company Valuation: AB Science

Data adjusted to current consolidation scope
Fiscal Period: December 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 332.2 180.9 57.55 112 46.57 - -
Change - -45.55% -68.19% 94.7% -58.44% - -
Enterprise Value (EV) 332.2 180.9 57.55 112 46.57 46.57 46.57
Change - -45.55% -68.19% 94.7% -58.44% 0% 0%
P/E -24.4x -17.8x -5.88x - - - -
PBR - - - - - - -
PEG - 0.6x 0.2x - - - -
Capitalization / Revenue - 187x 53.7x 95.4x 38.8x 35.8x 29.1x
EV / Revenue - 0x 0x 0x 38.8x 35.8x 29.1x
EV / EBITDA - - - - - - -
EV / EBIT - -0x -0x 0x -7.16x -7.28x -
EV / FCF - -0x - -0x -7.28x -12.9x -11.9x
FCF Yield - -9.52% - -4.08% -13.7% -7.73% -8.37%
Dividend per Share 2 - - - - - - -
Rate of return - - - - - - -
EPS 2 -0.29 -0.2 -0.15 - - - -
Distribution rate - - - - - - -
Net sales 1 - 0.97 1.072 1.174 1.2 1.3 1.6
EBITDA - -11.16 -5.416 - - - -
EBIT 1 - -13.43 -6.083 0.639 -6.5 -6.4 -
Net income -13.62 -10.05 -7.831 - - - -
Net Debt - - - - - - -
Reference price 2 7.0900 3.5550 0.8820 1.5360 0.5820 0.5820 0.5820
Nbr of stocks (in thousands) 46,861 50,891 65,248 72,947 80,015 - -
Announcement Date 01/03/23 15/05/24 13/05/25 13/05/26 - - -
1EUR in Million2EUR
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
32.9x11.93x24.23x0.6% 1,031B
29.45x6.54x18.31x2.02% 638B
33.1x7.75x16.02x2.65% 462B
105.72x5.91x25.05x2.35% 359B
19x4.63x11.48x2.87% 335B
20.37x5.28x13.08x3.03% 273B
20.79x4.31x12.28x2.05% 253B
26.62x6.92x12.32x2.39% 228B
-45.08x6.57x25.65x2.21% 185B
Average 26.98x 6.65x 17.60x 2.24% 418.21B
Weighted average by Cap. 32.10x 7.72x 18.90x 1.92%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA